JP2021528458A - 血管性認知症の治療におけるマンヌロン二酸組成物の使用 - Google Patents

血管性認知症の治療におけるマンヌロン二酸組成物の使用 Download PDF

Info

Publication number
JP2021528458A
JP2021528458A JP2020572804A JP2020572804A JP2021528458A JP 2021528458 A JP2021528458 A JP 2021528458A JP 2020572804 A JP2020572804 A JP 2020572804A JP 2020572804 A JP2020572804 A JP 2020572804A JP 2021528458 A JP2021528458 A JP 2021528458A
Authority
JP
Japan
Prior art keywords
total weight
composition
acid
mannuronedioic
diacid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020572804A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2020001643A5 (enExample
Inventor
ゲン、メイユ
シン、シャンリャン
ドゥ、シャオグアン
チャン、チェンチン
ディン、ジャン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Institute of Materia Medica of CAS
Shanghai Green Valley Pharmaceutical Co Ltd
Original Assignee
Shanghai Institute of Materia Medica of CAS
Shanghai Green Valley Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Institute of Materia Medica of CAS, Shanghai Green Valley Pharmaceutical Co Ltd filed Critical Shanghai Institute of Materia Medica of CAS
Publication of JP2021528458A publication Critical patent/JP2021528458A/ja
Publication of JPWO2020001643A5 publication Critical patent/JPWO2020001643A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2020572804A 2018-06-29 2019-06-28 血管性認知症の治療におけるマンヌロン二酸組成物の使用 Pending JP2021528458A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201810711863.8A CN110652523A (zh) 2018-06-29 2018-06-29 甘露糖醛二酸的组合物在治疗血管性痴呆症中的应用
CN201810711863.8 2018-06-29
PCT/CN2019/093813 WO2020001643A1 (zh) 2018-06-29 2019-06-28 甘露糖醛二酸的组合物在治疗血管性痴呆症中的应用

Publications (2)

Publication Number Publication Date
JP2021528458A true JP2021528458A (ja) 2021-10-21
JPWO2020001643A5 JPWO2020001643A5 (enExample) 2022-07-05

Family

ID=68985857

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020572804A Pending JP2021528458A (ja) 2018-06-29 2019-06-28 血管性認知症の治療におけるマンヌロン二酸組成物の使用

Country Status (7)

Country Link
US (1) US11406651B2 (enExample)
EP (1) EP3815694A4 (enExample)
JP (1) JP2021528458A (enExample)
KR (1) KR20210040039A (enExample)
CN (1) CN110652523A (enExample)
AU (1) AU2019296854A1 (enExample)
WO (1) WO2020001643A1 (enExample)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007530718A (ja) * 2004-03-24 2007-11-01 中国海洋大学 アルギンオリゴ糖及びその誘導体、並びにそれらの調製と用途
CN106344593A (zh) * 2015-07-17 2017-01-25 上海绿谷制药有限公司 褐藻胶寡糖及其衍生物在治疗血管性痴呆中的应用
JP2020507619A (ja) * 2016-12-30 2020-03-12 シャンハイ、グリーン、バレー、ファーマスーティカル、カンパニー、リミテッドＳｈａｎｇｈａｉ Ｇｒｅｅｎ Ｖａｌｌｅｙ Ｐｈａｒｍａｃｅｕｔｉｃａｌ Ｃｏ．， Ｌｔｄ． マンヌロン二酸の組成物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106344592A (zh) * 2015-07-17 2017-01-25 上海绿谷制药有限公司 还原端1位为羧基的甘露糖醛酸寡糖及其衍生物在治疗帕金森氏症中的应用

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007530718A (ja) * 2004-03-24 2007-11-01 中国海洋大学 アルギンオリゴ糖及びその誘導体、並びにそれらの調製と用途
CN106344593A (zh) * 2015-07-17 2017-01-25 上海绿谷制药有限公司 褐藻胶寡糖及其衍生物在治疗血管性痴呆中的应用
JP2020507619A (ja) * 2016-12-30 2020-03-12 シャンハイ、グリーン、バレー、ファーマスーティカル、カンパニー、リミテッドＳｈａｎｇｈａｉ Ｇｒｅｅｎ Ｖａｌｌｅｙ Ｐｈａｒｍａｃｅｕｔｉｃａｌ Ｃｏ．， Ｌｔｄ． マンヌロン二酸の組成物

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, vol. 32, JPN6023017193, 2006, pages 103 - 118, ISSN: 0005210979 *

Also Published As

Publication number Publication date
EP3815694A1 (en) 2021-05-05
US11406651B2 (en) 2022-08-09
CN110652523A (zh) 2020-01-07
US20210268006A1 (en) 2021-09-02
KR20210040039A (ko) 2021-04-12
EP3815694A4 (en) 2022-03-02
AU2019296854A1 (en) 2021-01-28
WO2020001643A1 (zh) 2020-01-02

Similar Documents

Publication Publication Date Title
JP6977059B2 (ja) マンヌロン二酸の組成物
JP7672226B2 (ja) アルギン酸オリゴサッカリン二酸の組成物
CN106344593B (zh) 褐藻胶寡糖及其衍生物在制备治疗血管性痴呆药物中的应用
US11406651B2 (en) Use of mannuronic diacid composition in treatment of vascular dementia
US11406654B2 (en) Use of mannuronic diacid composition in treatment of Parkinson's disease
US11406659B2 (en) Use of mannuronic diacid composition in treatment of inflammation
US11406652B2 (en) Use of mannuronic diacid composition in treatment of diabetes
HK40014916A (en) Use of a composition of oligomeric mannuronic diacid for treating vascular dementia
JP2021529196A (ja) 疼痛の治療におけるマンヌロン二酸組成物の使用
HK40014917A (en) Use of a composition of oligomeric mannuronic diacid for treating parkinson's disease
HK40016251A (en) Use of a composition of mannuronic diacids in the treatment of pain
EA041420B1 (ru) Композиции маннуроновой дикислоты, способы ее получения и использования

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220627

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20220627

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20230424

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230428

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20231205